Potent, selective benzenesulfonamide agonists of the human β3 adrenergic receptor

被引:32
作者
Weber, AE [1 ]
Mathvink, RJ
Perkins, L
Hutchins, JE
Candelore, MR
Tota, L
Strader, CD
Wyvratt, MJ
Fisher, MH
机构
[1] Merck Res Labs, Dept Med Chem & Biochem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Mol Pharmacol, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0960-894X(98)00169-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A cloned human beta(3) adrenergic receptor assay was used to identify phenoxypropanolamine agonist 1. SAR studies led to the identification of benzenesulfonamide derivative 20, a 6.3 nM beta(3) agonist which shows 30-fold selectivity for beta(3) agonist activity over beta(1) and beta(2) receptor binding. Further refinement of this lead provided 4-bromo derivative 39, a subnanomolar agonist with 660-fold and 230-fold selectivity over beta(1) and beta(2), respectively. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1101 / 1106
页数:6
相关论文
共 29 条
[1]  
Arch JRS, 1996, INT J OBESITY, V20, P191
[2]   ATYPICAL BETA-ADRENOCEPTOR ON BROWN ADIPOCYTES AS TARGET FOR ANTI-OBESITY DRUGS [J].
ARCH, JRS ;
AINSWORTH, AT ;
CAWTHORNE, MA ;
PIERCY, V ;
SENNITT, MV ;
THODY, VE ;
WILSON, C ;
WILSON, S .
NATURE, 1984, 309 (5964) :163-165
[3]   BETA(3)-ADRENOCEPTOR AND ATYPICAL BETA-ADRENOCEPTOR [J].
ARCH, JRS ;
KAUMANN, AJ .
MEDICINAL RESEARCH REVIEWS, 1993, 13 (06) :663-729
[4]   A simplified template approach towards the synthesis of a potent beta-3 adrenoceptor agonist at the human receptor [J].
Beeley, LJ ;
Berge, JM ;
Chapman, H ;
Dean, DK ;
Kelly, J ;
Lowden, K ;
Kotecha, NR ;
Morgan, HKA ;
Rami, HK ;
Thompson, M ;
Vong, AKK ;
Ward, RW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (02) :219-224
[5]   DISODIUM (R,R)-5-[2-[[2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO]PROPYL]-1,3-BENZODIOXOLE-2,2-DICARBOXYLATE (CL 316,243) - A POTENT BETA-ADRENERGIC AGONIST VIRTUALLY SPECIFIC FOR BETA-3 RECEPTORS - A PROMISING ANTIDIABETIC AND ANTIOBESITY AGENT [J].
BLOOM, JD ;
DUTIA, MD ;
JOHNSON, BD ;
WISSNER, A ;
BURNS, MG ;
LARGIS, EE ;
DOLAN, JA ;
CLAUS, TH .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (16) :3081-3084
[6]  
CAWTHORNE M A, 1992, American Journal of Clinical Nutrition, V55, p252S, DOI 10.1093/ajcn/55.1.252s
[7]  
CLAUS TH, 1995, ANNU REP MED CHEM, V30, P189
[8]   ARYLETHANOLAMINES DERIVED FROM SALICYLAMIDE WITH ALPHA-ADRENOCEPTOR AND BETA-ADRENOCEPTOR BLOCKING ACTIVITIES - PREPARATION OF LABETALOL, ITS ENANTIOMERS, AND RELATED SALICYLAMIDES [J].
CLIFTON, JE ;
COLLINS, I ;
HALLETT, P ;
HARTLEY, D ;
LUNTS, LHC ;
WICKS, PD .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (06) :670-679
[9]   WEIGHT-LOSS IN OBESE SUBJECTS ON A RESTRICTED DIET GIVEN BRL-26830A, A NEW ATYPICAL BETA-ADRENOCEPTOR AGONIST [J].
CONNACHER, AA ;
JUNG, RT ;
MITCHELL, PEG .
BRITISH MEDICAL JOURNAL, 1988, 296 (6631) :1217-1220
[10]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121